Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

NCT00092404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1210

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Mumps
Rubella
Varicella

Interventions

BIOLOGICAL: measles, mumps, and rubella virus vaccine live
BIOLOGICAL: Comparator: Measles, Mumps, and Rubella Virus Vaccine Live

Sponsor

Merck Sharp & Dohme LLC